Literature DB >> 21632696

Cure frailty models for survival data: application to recurrences for breast cancer and to hospital readmissions for colorectal cancer.

Virginie Rondeau1, Emmanuel Schaffner, Fabien Corbière, Juan R Gonzalez, Simone Mathoulin-Pélissier.   

Abstract

Owing to the natural evolution of a disease, several events often arise after a first treatment for the same subject. For example, patients with a primary invasive breast cancer and treated with breast conserving surgery may experience breast cancer recurrences, metastases or death. A certain proportion of subjects in the population who are not expected to experience the events of interest are considered to be 'cured' or non-susceptible. To model correlated failure time data incorporating a surviving fraction, we compare several forms of cure rate frailty models. In the first model already proposed non-susceptible patients are those who are not expected to experience the event of interest over a sufficiently long period of time. The other proposed models account for the possibility of cure after each event. We illustrate the cure frailty models with two data sets. First to analyse time-dependent prognostic factors associated with breast cancer recurrences, metastases, new primary malignancy and death. Second to analyse successive rehospitalizations of patients diagnosed with colorectal cancer. Estimates were obtained by maximization of likelihood using SAS proc NLMIXED for a piecewise constant hazards model. As opposed to the simple frailty model, the proposed methods demonstrate great potential in modelling multivariate survival data with long-term survivors ('cured' individuals).

Entities:  

Keywords:  Breast cancer; correlated survival times; cure frailty model; piecewise constant hazards

Mesh:

Year:  2011        PMID: 21632696     DOI: 10.1177/0962280210395521

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  11 in total

1.  Regression analysis of current status data in the presence of a cured subgroup and dependent censoring.

Authors:  Yeqian Liu; Tao Hu; Jianguo Sun
Journal:  Lifetime Data Anal       Date:  2016-09-30       Impact factor: 1.588

2.  A joint model for recurrent events and a semi-competing risk in the presence of multi-level clustering.

Authors:  Tae Hyun Jung; Peter Peduzzi; Heather Allore; Tassos C Kyriakides; Denise Esserman
Journal:  Stat Methods Med Res       Date:  2018-07-31       Impact factor: 3.021

3.  A Bayesian joint model of recurrent events and a terminal event.

Authors:  Zheng Li; Vernon M Chinchilli; Ming Wang
Journal:  Biom J       Date:  2018-11-26       Impact factor: 2.207

4.  Joint modeling of recurrent events and a terminal event adjusted for zero inflation and a matched design.

Authors:  Cong Xu; Vernon M Chinchilli; Ming Wang
Journal:  Stat Med       Date:  2018-04-22       Impact factor: 2.373

5.  The Log-Normal zero-inflated cure regression model for labor time in an African obstetric population.

Authors:  Hayala Cristina Cavenague de Souza; Francisco Louzada; Mauro Ribeiro de Oliveira; Bukola Fawole; Adesina Akintan; Lawal Oyeneyin; Wilfred Sanni; Gleici da Silva Castro Perdoná
Journal:  J Appl Stat       Date:  2021-03-09       Impact factor: 1.416

6.  Compound Poisson frailty model with a gamma process prior for the baseline hazard: accounting for a cured fraction.

Authors:  Maryam Rahmati; Parisa Rezanejad Asl; Javad Mikaeli; Hojjat Zeraati; Aliakbar Rasekhi
Journal:  J Appl Stat       Date:  2021-07-05       Impact factor: 1.416

7.  Joint model for bivariate zero-inflated recurrent event data with terminal events.

Authors:  Yang-Jin Kim
Journal:  J Appl Stat       Date:  2020-03-24       Impact factor: 1.416

8.  Model-based Recursive Partitioning for Survival of Iranian Female Breast Cancer Patients: Comparing with Parametric Survival Models.

Authors:  Mozhgan Safe; Javad Faradmal; Jalal Poorolajal; Hossein Mahjub
Journal:  Iran J Public Health       Date:  2017-01       Impact factor: 1.429

9.  Long-Term Disease-Free Survival of Non-Metastatic Breast Cancer Patients in Iran: A Survival Model with Competing Risks Taking Cure Fraction and Frailty into Account

Authors:  Vahid Ghavami; Mahmood Mahmoudi; Abbas Rahimi Foroushani; Hossein Baghishani; Fatemeh Homaei Shandiz; Mehdi Yaseri
Journal:  Asian Pac J Cancer Prev       Date:  2017-10-26

10.  A Comparison between Cure Model and Recursive Partitioning: A Retrospective Cohort Study of Iranian Female with Breast Cancer.

Authors:  Mozhgan Safe; Javad Faradmal; Hossein Mahjub
Journal:  Comput Math Methods Med       Date:  2016-08-28       Impact factor: 2.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.